Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis

NCT02603068 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Study design was inadequate and would not achieve study endpoints

Conditions

Pulmonary Hypertension
Pulmonary Fibrosis

Interventions

DRUG: Oral treprostinil

Sponsor

United Therapeutics